Highlights From AACR IO 2026: Breaching the Tumor Microenvironment Fortress With New CAR T and Chimeras
Three innovative studies at AACR IO 2026 presented new ways for CAR T cells and antibody-lectin chimeras to tackle...
Three innovative studies at AACR IO 2026 presented new ways for CAR T cells and antibody-lectin chimeras to tackle...
August’s edition of Editors’ Picks includes biomarkers of immunotherapy response, individualized colorectal screening guidelines, and other exciting research.
The Global Scholar Alumni Committee reflects on their progress after the first year in helping the careers of young...
New research improves physicians' “molecular chess” game against thyroid cancer to overcome resistance to treatments.
Researchers developed a model that uses the gut microbiome to predict if a patient's tumor would have a response...
Expanding clinical trial eligibility requirements can help increase participation and more accurately show how treatments work in a real-world...
This quarter's round-up of cutting-edge cancer research includes a way to fight chemo brain, controlling cancer cell death, and...
New cervical cancer self-screening options and a portable blood test device could lead to changes in at-home cancer screening...
Clinical trials for dogs with cancer can extend the lives of our four-legged friends while revealing insights about cancer...
The AACR journal editors' picks for July 2024 include a review of the risks from CAR T-cell therapy, advances...
Highlights from a workshop and journal article that shared key considerations for including overall survival as an endpoint in...